Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors.

E. Bombardieri, E. Seregni, G. Savelli, C. Villano, M. R. Castellani, F. Cirillo, F. Pallotti, S. Fracassi, C. Chiesa, A. Chiti, E. Bajetta

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)63-69
Number of pages7
JournalJournal of Endocrinological Investigation
Issue number8 Suppl
Publication statusPublished - 2003

ASJC Scopus subject areas

  • Endocrinology

Cite this